CRISPR Therapeutics Milestones And ARK Backing Contrast With Valuation Gap [Yahoo! Finance]
CRISPR Therapeutics AG - Common Shares (CRSP)
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
nasdaq.com/symbol/crsp/real-time
Company Research
Source: Yahoo! Finance
CRISPR Therapeutics (NasdaqGM:CRSP) has set new 2026 milestones, including planned regulatory submissions for Casgevy in patients aged 5 to 11. The company outlined progress in several clinical programs that extend beyond its first approved gene editing therapy. CRISPR Therapeutics also highlighted expanded partnerships that support its gene editing pipeline. ARK Investment Management has repeatedly increased its stake in the company, indicating continued investor interest in its programs. CRISPR Therapeutics focuses on gene editing treatments, with Casgevy as its first approved therapy. The new 2026 milestones around younger patients and multiple programs describe how the company is working to build on that initial approval. For you as an investor, this update offers more clarity on where management is directing clinical and regulatory efforts next. The planned regulatory submissions and ARK Investment's larger position may influence how the story around NasdaqGM:CRSP deve
Show less
Read more
Impact Snapshot
Event Time:
CRSP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CRSP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CRSP alerts
High impacting CRISPR Therapeutics AG - Common Shares news events
Weekly update
A roundup of the hottest topics
CRSP
News
- CRISPR Therapeutics (NASDAQ:CRSP) had its price target lowered by analysts at Citizens Jmp from $86.00 to $80.00. They now have a "market outperform" rating on the stock.MarketBeat
- CRISPR Therapeutics (NASDAQ:CRSP) had its "market outperform" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
- Forget AI Stocks: This Biotech Could Cure What AI Can't Touch [Yahoo! Finance]Yahoo! Finance
- BofA is Bullish on CRISPR Therapeutics AG (CRSP) [Yahoo! Finance]Yahoo! Finance
- Is CRISPR Therapeutics (CRSP) Still Attractive After A 67% Five Year Share Price Decline [Yahoo! Finance]Yahoo! Finance
CRSP
Earnings
- 11/10/25 - Beat
CRSP
Sec Filings
- 1/27/26 - Form 4
- 1/26/26 - Form 4
- 1/22/26 - Form 4
- CRSP's page on the SEC website